Furthermore, compared with the control group, the serum levels of IL-18 and IL-1β in DCM mice were increased, and CVB-D treatment could inhibit the serum levels of these two pro-inflammatory cytokines (Figures 4D,E). The gene discussed is IL18; the disease is familial dilated cardiomyopathy.